Biolog Device Co., Ltd. (KOSDAQ:208710)
585.00
+5.00 (0.86%)
At close: Mar 31, 2025, 3:30 PM KST
Biolog Device Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Operating Revenue | 135,706 | 123,469 | 104,283 | 83,834 | 91,793 | Upgrade
|
Other Revenue | -0 | - | - | -0 | - | Upgrade
|
Revenue | 135,706 | 123,469 | 104,283 | 83,834 | 91,793 | Upgrade
|
Revenue Growth (YoY) | 9.91% | 18.40% | 24.39% | -8.67% | 1.52% | Upgrade
|
Cost of Revenue | 131,048 | 118,898 | 95,715 | 80,555 | 87,522 | Upgrade
|
Gross Profit | 4,658 | 4,571 | 8,568 | 3,279 | 4,271 | Upgrade
|
Selling, General & Admin | 7,243 | 6,696 | 6,823 | 7,914 | 6,581 | Upgrade
|
Research & Development | - | - | 54.52 | 1,257 | 1,344 | Upgrade
|
Other Operating Expenses | 157.34 | 80.87 | 115.98 | 216.46 | 112.55 | Upgrade
|
Operating Expenses | 7,873 | 9,633 | 7,893 | 13,087 | 8,589 | Upgrade
|
Operating Income | -3,215 | -5,062 | 674.99 | -9,808 | -4,318 | Upgrade
|
Interest Expense | -740.01 | -1,818 | -1,930 | -2,054 | -1,816 | Upgrade
|
Interest & Investment Income | 145.53 | 730.86 | 299.7 | 175.35 | 44.79 | Upgrade
|
Earnings From Equity Investments | - | -690.29 | -209.71 | 4,309 | -9,136 | Upgrade
|
Currency Exchange Gain (Loss) | 2,984 | -77.55 | 1,768 | 1,921 | -962.42 | Upgrade
|
Other Non Operating Income (Expenses) | -1,058 | -78.3 | -709.88 | -3,849 | -379.91 | Upgrade
|
EBT Excluding Unusual Items | -1,884 | -6,995 | -106.94 | -9,306 | -16,567 | Upgrade
|
Impairment of Goodwill | - | - | -151.66 | - | - | Upgrade
|
Gain (Loss) on Sale of Investments | - | 1,171 | 120.43 | - | - | Upgrade
|
Gain (Loss) on Sale of Assets | -1,818 | -1,855 | 5,629 | 210.57 | 45.23 | Upgrade
|
Asset Writedown | -3.46 | -153.75 | -603.44 | -88.49 | - | Upgrade
|
Pretax Income | -3,706 | -7,833 | 4,888 | -9,184 | -16,522 | Upgrade
|
Income Tax Expense | 2,374 | 155.32 | 3,067 | -1,281 | 373.49 | Upgrade
|
Earnings From Continuing Operations | -6,080 | -7,989 | 1,820 | -7,903 | -16,895 | Upgrade
|
Earnings From Discontinued Operations | -3,531 | -5,737 | -1,422 | 16.82 | - | Upgrade
|
Net Income to Company | -9,611 | -13,726 | 398.28 | -7,887 | -16,895 | Upgrade
|
Minority Interest in Earnings | -143.34 | 1,916 | -140.9 | 672.91 | - | Upgrade
|
Net Income | -9,754 | -11,810 | 257.38 | -7,214 | -16,895 | Upgrade
|
Net Income to Common | -9,754 | -11,810 | 257.38 | -7,214 | -16,895 | Upgrade
|
Shares Outstanding (Basic) | 64 | 47 | 42 | 38 | 29 | Upgrade
|
Shares Outstanding (Diluted) | 64 | 47 | 42 | 38 | 29 | Upgrade
|
Shares Change (YoY) | 36.04% | 12.36% | 9.39% | 32.86% | -14.20% | Upgrade
|
EPS (Basic) | -153.00 | -252.00 | 6.17 | -189.19 | -588.69 | Upgrade
|
EPS (Diluted) | -153.00 | -252.00 | 6.17 | -189.19 | -588.69 | Upgrade
|
Free Cash Flow | -5,213 | 3,657 | 3,107 | -5,723 | -19,966 | Upgrade
|
Free Cash Flow Per Share | -81.78 | 78.04 | 74.49 | -150.11 | -695.70 | Upgrade
|
Gross Margin | 3.43% | 3.70% | 8.22% | 3.91% | 4.65% | Upgrade
|
Operating Margin | -2.37% | -4.10% | 0.65% | -11.70% | -4.70% | Upgrade
|
Profit Margin | -7.19% | -9.56% | 0.25% | -8.61% | -18.41% | Upgrade
|
Free Cash Flow Margin | -3.84% | 2.96% | 2.98% | -6.83% | -21.75% | Upgrade
|
EBITDA | 4,050 | 3,233 | 8,627 | -1,908 | 4,633 | Upgrade
|
EBITDA Margin | 2.99% | 2.62% | 8.27% | -2.28% | 5.05% | Upgrade
|
D&A For EBITDA | 7,266 | 8,295 | 7,952 | 7,900 | 8,951 | Upgrade
|
EBIT | -3,215 | -5,062 | 674.99 | -9,808 | -4,318 | Upgrade
|
EBIT Margin | -2.37% | -4.10% | 0.65% | -11.70% | -4.70% | Upgrade
|
Effective Tax Rate | - | - | 62.76% | - | - | Upgrade
|
Advertising Expenses | 4.4 | 0.35 | 16.95 | 2.88 | 47.67 | Upgrade
|
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.